U.S. Intrauterine Devices Market Size & Forecast 2025–2034

U.S. Intrauterine Devices Market - By Product, By Age Group, By End Use - Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Country

1.3.2&nbsp;&nbsp;&nbsp; Zone/State

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Zonal trends

2.2.2&nbsp;&nbsp;&nbsp; Product trends

2.2.3&nbsp;&nbsp;&nbsp; Age group trends

2.2.4&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Favorable regulatory scenario

3.2.1.2&nbsp;&nbsp;&nbsp; Rising awareness among women regarding various IUD applications

3.2.1.3&nbsp;&nbsp;&nbsp; High number of unintended pregnancies

3.2.1.4&nbsp;&nbsp;&nbsp; Government initiatives for the prevention of unwanted abortions and pregnancies

3.2.1.5&nbsp;&nbsp;&nbsp; Growing inclination towards planned delayed pregnancy

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of the device

3.2.2.2&nbsp;&nbsp;&nbsp; Risk of several health issues

3.2.2.3&nbsp;&nbsp;&nbsp; Variability in insurance coverage and access

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Rising demand for long-term contraception

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technological landscape

3.5.1&nbsp;&nbsp;&nbsp; Current technologies

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.8&nbsp;&nbsp;&nbsp; Consumer behaviour and trends

3.9&nbsp;&nbsp;&nbsp; Brand analysis

3.10&nbsp;&nbsp;&nbsp; Pipeline analysis

3.11&nbsp;&nbsp;&nbsp; U.S. intrauterine device units sold, by brand, 2021 - 2034

3.12&nbsp;&nbsp;&nbsp; Therapeutic applications beyond contraception

3.13&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.14&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.15&nbsp;&nbsp;&nbsp; PESTEL analysis

3.16&nbsp;&nbsp;&nbsp; Gap analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Copper IUD

5.3&nbsp;&nbsp;&nbsp; Hormonal IUD

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Age Group, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; 15-19

6.3&nbsp;&nbsp;&nbsp; 20-24

6.4&nbsp;&nbsp;&nbsp; 25-29

6.5&nbsp;&nbsp;&nbsp; 30-34

6.6&nbsp;&nbsp;&nbsp; 35-39

6.7&nbsp;&nbsp;&nbsp; 40-44

6.8&nbsp;&nbsp;&nbsp; 45+

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Gynecology clinics

7.4&nbsp;&nbsp;&nbsp; Community health care centers

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Zone, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; East North Central

8.2.1&nbsp;&nbsp;&nbsp; Illinois

8.2.2&nbsp;&nbsp;&nbsp; Indiana

8.2.3&nbsp;&nbsp;&nbsp; Michigan

8.2.4&nbsp;&nbsp;&nbsp; Ohio

8.2.5&nbsp;&nbsp;&nbsp; Wisconsin

8.3&nbsp;&nbsp;&nbsp; West South Central

8.3.1&nbsp;&nbsp;&nbsp; Arkansas

8.3.2&nbsp;&nbsp;&nbsp; Louisiana

8.3.3&nbsp;&nbsp;&nbsp; Oklahoma

8.3.4&nbsp;&nbsp;&nbsp; Texas

8.4&nbsp;&nbsp;&nbsp; South Atlantic

8.4.1&nbsp;&nbsp;&nbsp; Delaware

8.4.2&nbsp;&nbsp;&nbsp; Florida

8.4.3&nbsp;&nbsp;&nbsp; Georgia

8.4.4&nbsp;&nbsp;&nbsp; Maryland

8.4.5&nbsp;&nbsp;&nbsp; North Carolina

8.4.6&nbsp;&nbsp;&nbsp; South Carolina

8.4.7&nbsp;&nbsp;&nbsp; Virginia

8.4.8&nbsp;&nbsp;&nbsp; West Virginia

8.4.9&nbsp;&nbsp;&nbsp; Washington, D.C.

8.5&nbsp;&nbsp;&nbsp; Northeast

8.5.1&nbsp;&nbsp;&nbsp; Connecticut

8.5.2&nbsp;&nbsp;&nbsp; Maine

8.5.3&nbsp;&nbsp;&nbsp; Massachusetts

8.5.4&nbsp;&nbsp;&nbsp; New Hampshire

8.5.5&nbsp;&nbsp;&nbsp; Rhode Island

8.5.6&nbsp;&nbsp;&nbsp; Vermont

8.5.7&nbsp;&nbsp;&nbsp; New Jersey

8.5.8&nbsp;&nbsp;&nbsp; New York

8.5.9&nbsp;&nbsp;&nbsp; Pennsylvania

8.6&nbsp;&nbsp;&nbsp; East South Central

8.6.1&nbsp;&nbsp;&nbsp; Alabama

8.6.2&nbsp;&nbsp;&nbsp; Kentucky

8.6.3&nbsp;&nbsp;&nbsp; Mississippi

8.6.4&nbsp;&nbsp;&nbsp; Tennessee

8.7&nbsp;&nbsp;&nbsp; West North Central

8.7.1&nbsp;&nbsp;&nbsp; Iowa

8.7.2&nbsp;&nbsp;&nbsp; Kansas

8.7.3&nbsp;&nbsp;&nbsp; Minnesota

8.7.4&nbsp;&nbsp;&nbsp; Missouri

8.7.5&nbsp;&nbsp;&nbsp; Nebraska

8.7.6&nbsp;&nbsp;&nbsp; North Dakota

8.7.7&nbsp;&nbsp;&nbsp; South Dakota

8.8&nbsp;&nbsp;&nbsp; Pacific Central

8.8.1&nbsp;&nbsp;&nbsp; Alaska

8.8.2&nbsp;&nbsp;&nbsp; California

8.8.3&nbsp;&nbsp;&nbsp; Hawaii

8.8.4&nbsp;&nbsp;&nbsp; Oregon

8.8.5&nbsp;&nbsp;&nbsp; Washington

8.9&nbsp;&nbsp;&nbsp; Mountain States

8.9.1&nbsp;&nbsp;&nbsp; Arizona

8.9.2&nbsp;&nbsp;&nbsp; Colorado

8.9.3&nbsp;&nbsp;&nbsp; Utah

8.9.4&nbsp;&nbsp;&nbsp; Nevada

8.9.5&nbsp;&nbsp;&nbsp; New Mexico

8.9.6&nbsp;&nbsp;&nbsp; Idaho

8.9.7&nbsp;&nbsp;&nbsp; Montana

8.9.8&nbsp;&nbsp;&nbsp; Wyoming

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; AbbVie

9.2&nbsp;&nbsp;&nbsp; Bayer

9.3&nbsp;&nbsp;&nbsp; CooperSurgical

9.4&nbsp;&nbsp;&nbsp; DKT

9.5&nbsp;&nbsp;&nbsp; Medicines360

9.6&nbsp;&nbsp;&nbsp; Sebela Pharmaceuticals

&nbsp;&nbsp;&nbsp;

U.S. Intrauterine Devices Market

Inquiry Before Buying